Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for GABA derivative intermediates featuring high purity and mild conditions. Enables cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN104693019B reveals a safer route for 2 5-dibromo phenylacetic acid. Achieve high purity and cost reduction in pharma intermediates manufacturing with scalable methods.
Novel HCl-based ring-opening chlorination method for (S)-4-chloro-2-aminobutyrate. Reduces thionyl chloride waste, improves yield, ensures scalable supply for glufosinate synthesis.
Novel hydroxylase method reduces cis-3-hydroxy impurity for pharmaceutical intermediates. Scalable biocatalysis ensures cost efficiency and supply reliability.
Patent CN113336738A details a green synthesis route for shikimic acid ethers using recyclable cation exchange resins, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN107778227B reveals a robust route for 4-fluoro-6-trifluoromethyl-3-picolinic acid. Discover cost-effective synthesis strategies for high-purity agrochemical intermediates.
Patent CN105331650A reveals enzymatic co-production reducing cofactor costs. Enhances supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1096450C reveals a high-yield process for chiral herbicide intermediates. Discover cost reduction in agrochemical manufacturing and supply chain reliability.
Patent CN106119272A reveals efficient enzymatic co-production reducing cofactor costs for pharmaceutical intermediate manufacturing supply chains and enhancing scalability.
Patent CN108546691B discloses a novel 7β-HSDH mutant utilizing cheap NADH for ursodeoxycholic acid production, offering significant cost reduction and scalable biocatalysis solutions.
Patent CN107099516A details high-efficiency enzymatic UDCA production. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Novel PTC-catalyzed oxidation of 3,5-lutidine yields high-purity 5-methylnicotinic acid. Reduces water usage and boosts efficiency for Rupatadine manufacturing.
Novel Aeromonas caviae B18 strain enables high-purity chiral intermediate production with reduced costs and simplified downstream processing for pharma.
Patent CN101759625A details a robust synthesis for 2,4-dimethyl-5-formyl-1H-pyrrole-3-carboxylic acid, offering safer conditions and scalable production for global supply chains.
Novel synthesis of GSK484 fragment avoids microwave reaction. Cost-effective scale-up for pharmaceutical intermediates supply chain.
Patent CN113292517A reveals a mild anion exchange resin method for shikimic acid epoxide synthesis, offering 98-100% yield and enhanced supply chain safety.
Patent CN108300744A reveals enzymatic synthesis for high purity D-heterocyclic amino acids. This technology reduces cost and improves supply chain reliability for global pharmaceutical buyers seeking scalable intermediates.
Patent CN110204547A reveals a safer two-step synthesis for 1,3-dimethyl uric acid, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1181053C details a high-fidelity synthesis of 3-(7-amidino-2-naphthyl) derivatives, ensuring optical purity for thrombin inhibitor manufacturing.